p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment

Neuroblastoma (NB) is the second most common solid pediatric tumor and is characterized by clinical and biological heterogeneity, and stage-IV of the disease represents 50% of all cases. Considering the limited success of present chemotherapy treatment, it has become necessary to find new and effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Marengo, B, De Ciucis, C G, Ricciarelli, R, Furfaro, A L, Colla, R, Canepa, E, Traverso, N, Marinari, U M, Pronzato, M A, Domenicotti, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641341/
https://www.ncbi.nlm.nih.gov/pubmed/23579276
http://dx.doi.org/10.1038/cddis.2013.118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641341/
https://www.ncbi.nlm.nih.gov/pubmed/23579276
http://dx.doi.org/10.1038/cddis.2013.118

Ejemplares similares